The NYT Editorial Board Statement—Mike on Medtech

The NYT Editorial Board Statement—Mike on Medtech

Sean Fenske and Mike Drues discuss the recent comments made by the Board about the medical device industry and FDA.

By Sean Fenske, Editor-in-Chief06.17.19
In this Medtech Matters podcast episode of Mike on Medtech with Mike Drues, president of Vascular Sciences, we discuss the subject of my latest Editor’s Letter, which appeared in the June issue of MPO (click here to read that Letter). It features yet another PR hit on the industry along with recommendations on what can be done to fix the problem (click here to read the NY Times Editorial Board statement). Of course, those fixes are rather general in how they are presented, but we dig into each of the three and share our own thoughts on the proposed solutions. Specifically, we address a number of questions, including:

  • Should products that are intended to reside in the body for an extended period of time require a PMA pathway? How would that compare to the current protocol?
  • Would an "implantable 510(k)" be a middle ground to address the issue—does not require a full PMA, but updates to implantable products can’t go through the standard 510(k) pathway either?
  • Might making sub-pathways or application specific pathways open up a problematic can of worms or would application specific approvals be a good idea?
  • What are the problems with the current system for post-market surveillance?
  • The statement claims that some companies don’t do appropriate post-market surveillance even when ordered. Why wouldn’t the FDA step in when this occurs and withdraw the company’s ability to market a product if they aren’t fulfilling their responsibilities?
  • Does the fact that the device industry funding the FDA’s work make them “customers” as the statement claims? Are the fees contingent on speed of approval and the least restrictive pathway possible?

Listen to this episode and see what you think regarding the FDA’s decision to cancel the alternative summary reporting program. If you’d like to share thoughts and comments with us or have questions on the topic, please reach out to me with them at sfenske@rodmanmedia.com so I can consider discussing them with Mike in an upcoming episode.

Listen to the podcast streaming via the player or get the podcast on the Medtech Matters channel via your preferred vendor of podcasts, such as Apple Podcasts (iTunes) or Spotify.

Once you’ve had a chance to listen to the podcast, if you have any questions or comments you’d like us to discuss or share with other Mike on Medtech listeners about this topic or any other topic we’ve addressed, or you have a suggestion for a future topic for us to cover, email me and we’ll try to respond in an upcoming Mike on Medtech podcast.

Click here to review other podcasts.
Related Searches:
Suggested For You